5 Best Stocks Under $20 According to Billionaire Andreas Halvorsen’s Viking Global

2. BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Viking Global’s Stake Value: $444 million

Percentage of Viking Global’s 13F Portfolio: 1.28%

Number of Hedge Fund Holders: 25

Share Price on April 26, 2022: $9.61

BridgeBio Pharma, Inc. (NASDAQ:BBIO) is an American biopharmaceutical company headquartered in Palo Alto, California. It develops products that are used to treat a host of genetic diseases such as amyloidosis-cardiomyopathy, congenital adrenal hyperplasia, and Autosomal Dominant Hypocalcemia Type 1.

For its fiscal fourth quarter, BridgeBio Pharma, Inc. (NASDAQ:BBIO) had brought in $12.8 million in revenue and -$1.01 in GAAP EPS, missing analyst estimates for both. H.C. Wainwright reduced the company’s share price target to $22 from $24 in March 2022.

Viking Global had owned 26.6 million BridgeBio Pharma, Inc. (NASDAQ:BBIO) shares as part of its fourth quarter of 2021 investment portfolio. These were worth $444 million. Insider Monkey raked through 924 hedge fund portfolios for Q4 2021 to find out that 25 had also invested in the company.

BridgeBio Pharma, Inc. (NASDAQ:BBIO)’s largest investor after Mr. Halvorsen’s hedge fund is Joseph Edelman’s Perceptive Advisors which owns seven million shares that are worth $118 million.